Prostate News Archive
09-Jun-2011
New Prostate Cancer Drugs Offer Hope
prostate cancer is the most common cancer among men, usually occurring at or after age 50, and the leading cause of death in men throughout the world. The cancer, which begins in the prostate gland of the male reproductive system, sometimes spreads to the bone and may be resistant to hormonal therapy. Prostate cancer drugs may extend survival
prostate cancer is the most common cancer in men, looming as a specter for many as they grow older. So far, this week's headlines about prostate cancer research have been fairly positive, with results from two trials showing promise for extending survival among men with late-stage forms of the cancer. Here?s a look at the latest developments: Safe to skip radiation for prostate cancer?
A review of recent studies comparing different radiation treatments for prostate cancer reveals no clear picture of what works best for the majority of men with the disease. Prostate Cancer News: Robotic Surgery Adoption Is Prompting More Men To Choose Prostatectomy
The rapid adoption of robotic prostatectomy in the US is leading more men to choose surgery as their primary treatment for prostate cancer, according to a study presented at the annual American Urological Association meeting and co-authored by Dr.
Back to Prostate News Archive
